The Government of Canada has a signed agreement with Eli Lilly for an initial order of up to 26,000 doses of their COVID-19 monoclonal antibody therapy Bamlanivimab (LY-CoV555). Under the agreement, deliveries of Bamlanivimab will begin in December 2020 and be completed in February 2021....